CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to APLS

APL-2, Pegcetacoplan

Phase 3
Apellis Pharmaceuticals, Inc. (APLS)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

3 competitors in Geographic Atrophy Secondary to Age-related Macular Degeneration

View Full Landscape
Drug Information

Target Indication

Geographic Atrophy Secondary to Age-related Macular Degeneration

Clinical Trial

NCT07214740

Last updated: 12/18/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.